BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao J, Chen X, Herjan T, Li X. The role of interleukin-17 in tumor development and progression. J Exp Med 2020;217:e20190297. [PMID: 31727782 DOI: 10.1084/jem.20190297] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 32.0] [Reference Citation Analysis]
Number Citing Articles
1 Rusiñol L, Camiña-conforto G, Puig L. Biologic treatment of psoriasis in oncologic patients. Expert Opinion on Biological Therapy 2022. [DOI: 10.1080/14712598.2022.2152322] [Reference Citation Analysis]
2 Cui G, Wang Z, Liu H, Pang Z. Cytokine-mediated crosstalk between cancer stem cells and their inflammatory niche from the colorectal precancerous adenoma stage to the cancerous stage: Mechanisms and clinical implications. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1057181] [Reference Citation Analysis]
3 Eshwar V, Kamath A, Shastry R, Shenoy AK, Kamath P. A Review of the Safety of Interleukin-17A Inhibitor Secukinumab. Pharmaceuticals 2022;15:1365. [DOI: 10.3390/ph15111365] [Reference Citation Analysis]
4 Budek M, Nuszkiewicz J, Piórkowska A, Czuczejko J, Szewczyk-Golec K. Inflammation Related to Obesity in the Etiopathogenesis of Gastroenteropancreatic Neuroendocrine Neoplasms. Biomedicines 2022;10:2660. [PMID: 36289922 DOI: 10.3390/biomedicines10102660] [Reference Citation Analysis]
5 Knizkova D, Pribikova M, Draberova H, Semberova T, Trivic T, Synackova A, Ujevic A, Stefanovic J, Drobek A, Huranova M, Niederlova V, Tsyklauri O, Neuwirth A, Tureckova J, Stepanek O, Draber P. CMTM4 is a subunit of the IL-17 receptor and mediates autoimmune pathology. Nat Immunol 2022. [PMID: 36271145 DOI: 10.1038/s41590-022-01325-9] [Reference Citation Analysis]
6 Zhang X, Qin X, Yu T, Wang K, Chen Y, Xing Q. Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation. Front Genet 2022;13:974726. [DOI: 10.3389/fgene.2022.974726] [Reference Citation Analysis]
7 Jiang X, Zhou R, Zhang Y, Zhu T, Li Q, Zhang W. Interleukin-17 as a potential therapeutic target for chronic pain. Front Immunol 2022;13:999407. [DOI: 10.3389/fimmu.2022.999407] [Reference Citation Analysis]
8 Villarreal-garcía V, Estupiñan-jiménez JR, Vivas-mejía PE, Gonzalez-villasana V, Vázquez-guillén JM, Reséndez-pérez D. A vicious circle in breast cancer: The interplay between inflammation, reactive oxygen species, and microRNAs. Front Oncol 2022;12:980694. [DOI: 10.3389/fonc.2022.980694] [Reference Citation Analysis]
9 Almeida-nunes DL, Mendes-frias A, Silvestre R, Dinis-oliveira RJ, Ricardo S. Immune Tumor Microenvironment in Ovarian Cancer Ascites. IJMS 2022;23:10692. [DOI: 10.3390/ijms231810692] [Reference Citation Analysis]
10 Han X, Ye J, Huang R, Li Y, Liu J, Meng T, Song D. Pan-cancer analysis reveals interleukin-17 family members as biomarkers in the prediction for immune checkpoint inhibitor curative effect. Front Immunol 2022;13:900273. [DOI: 10.3389/fimmu.2022.900273] [Reference Citation Analysis]
11 Mirzaei R, Yong VW. Microglia-T cell conversations in brain cancer progression. Trends Mol Med 2022:S1471-4914(22)00211-8. [PMID: 36075812 DOI: 10.1016/j.molmed.2022.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Dong M, Zhang J, Chen Q, He D, Yan H, Zheng G, Han X, He J, Cai Z. High serum IL-17A is associated with bone destruction in newly diagnosed multiple myeloma patients. Front Oncol 2022;12:936670. [DOI: 10.3389/fonc.2022.936670] [Reference Citation Analysis]
13 Jarocki M, Karska J, Kowalski S, Kiełb P, Nowak Ł, Krajewski W, Saczko J, Kulbacka J, Szydełko T, Małkiewicz B. Interleukin 17 and Its Involvement in Renal Cell Carcinoma. JCM 2022;11:4973. [DOI: 10.3390/jcm11174973] [Reference Citation Analysis]
14 Turchin I, Bourcier M. The Role of Interleukins in the Pathogenesis of Dermatological Immune-Mediated Diseases. Adv Ther 2022. [PMID: 35997892 DOI: 10.1007/s12325-022-02241-y] [Reference Citation Analysis]
15 Kopelyanskiy D, Desponds C, Prevel F, Rossi M, Migliorini R, Snäkä T, Eren RO, Claudinot S, Lye L, Pasparakis M, Beverley SM, Fasel N. Leishmania guyanensis suppressed inducible nitric oxide synthase provoked by its viral endosymbiont. Front Cell Infect Microbiol 2022;12:944819. [DOI: 10.3389/fcimb.2022.944819] [Reference Citation Analysis]
16 Sun H, Tang C, Chung SH, Ye XQ, Makusheva Y, Han W, Kubo M, Shichino S, Ueha S, Matsushima K, Ikeo K, Asano M, Iwakura Y. Blocking DCIR mitigates colitis and prevents colorectal tumors by enhancing the GM-CSF-STAT5 pathway. Cell Rep 2022;40:111158. [PMID: 35926458 DOI: 10.1016/j.celrep.2022.111158] [Reference Citation Analysis]
17 Cook CJ, Miller AE, Barker TH, Di Y, Fogg KC. Characterizing the extracellular matrix transcriptome of cervical, endometrial, and uterine cancers. Matrix Biol Plus 2022;15:100117. [PMID: 35898192 DOI: 10.1016/j.mbplus.2022.100117] [Reference Citation Analysis]
18 Urbiola-salvador V, Miroszewska D, Jabłońska A, Qureshi T, Chen Z. Proteomics approaches to characterize the immune responses in cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2022;1869:119266. [DOI: 10.1016/j.bbamcr.2022.119266] [Reference Citation Analysis]
19 Gayathri M, Lavanya V, Jamal S, Ahmed N. Targeting Soluble Factors Involved in Inflammatory Cancer Microenvironment. Curr Pharmacol Rep 2022;8:253-261. [DOI: 10.1007/s40495-022-00291-y] [Reference Citation Analysis]
20 D. Radosavljevic G, Pantic J, Simovic Markovic B, Arsenijevic N. Modulators of Tumor Angiogenesis: Insights into the Role of Galectin-3 and IL-17 Signaling. Tumor Angiogenesis and Modulators 2022. [DOI: 10.5772/intechopen.102893] [Reference Citation Analysis]
21 Chen Y, Wu F, Wu P, Xing H, Ma T. The Role of The Tumor Microbiome in Tumor Development and Its Treatment. Front Immunol 2022;13:935846. [DOI: 10.3389/fimmu.2022.935846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Boehncke WH, Brembilla NC. Pathogenesis-oriented therapy of psoriasis using biologics. Expert Opin Biol Ther 2022. [PMID: 35815360 DOI: 10.1080/14712598.2022.2100219] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Mills KHG. IL-17 and IL-17-producing cells in protection versus pathology. Nat Rev Immunol 2022. [PMID: 35790881 DOI: 10.1038/s41577-022-00746-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
24 Janiczek-polewska M, Szylberg Ł, Malicki J, Marszałek A. Role of Interleukins and New Perspectives in Mechanisms of Resistance to Chemotherapy in Gastric Cancer. Biomedicines 2022;10:1600. [DOI: 10.3390/biomedicines10071600] [Reference Citation Analysis]
25 Molka B, Gwladys B, Dorian B, Lucie M, Mustapha B, Rosalie C, Brigitte G, Hafida K, Moncef B. Follicular Fluid Growth Factors and Interleukin Profiling as Potential Predictors of IVF Outcomes. Front Physiol 2022;13:859790. [DOI: 10.3389/fphys.2022.859790] [Reference Citation Analysis]
26 Benot-Dominguez R, Cimini A, Barone D, Giordano A, Pentimalli F. The Emerging Role of Cyclin-Dependent Kinase Inhibitors in Treating Diet-Induced Obesity: New Opportunities for Breast and Ovarian Cancers? Cancers (Basel) 2022;14:2709. [PMID: 35681689 DOI: 10.3390/cancers14112709] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Nam D, Rhee J. Assessment of MicroRNAs Associated with Tumor Purity by Random Forest Regression. Biology 2022;11:787. [DOI: 10.3390/biology11050787] [Reference Citation Analysis]
28 Mann AO, Hanna BS, Muñoz-Rojas AR, Sandrock I, Prinz I, Benoist C, Mathis D. IL-17A-producing γδT cells promote muscle regeneration in a microbiota-dependent manner. J Exp Med 2022;219:e20211504. [PMID: 35380608 DOI: 10.1084/jem.20211504] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
29 Cook CJ, Miller AE, Barker TH, Di Y, Fogg KC. Characterizing the extracellular matrix transcriptome of cervical, endometrial, and uterine cancers.. [DOI: 10.1101/2022.04.04.486998] [Reference Citation Analysis]
30 Mills KHG. Innate lymphoid cells recruit T cells to turn up the heat on tumors. Cancer Cell 2022:S1535-6108(22)00117-9. [PMID: 35334205 DOI: 10.1016/j.ccell.2022.03.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
31 Huang Y, Zhu N, Zheng X, Liu Y, Lu H, Yin X, Hao H, Tan Y, Wang D, Hu H, Liang Y, Li X, Hu Z, Yin Y. Intratumor Microbiome Analysis Identifies Positive Association Between Megasphaera and Survival of Chinese Patients With Pancreatic Ductal Adenocarcinomas. Front Immunol 2022;13:785422. [DOI: 10.3389/fimmu.2022.785422] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
32 Zhang Y, Xie Y, Feng Y, Wang Y, Xu X, Zhu S, Xu F, Feng N. Construction and verification of a prognostic risk model based on immunogenomic landscape analysis of bladder caner. Gene 2022;808:145966. [PMID: 34530089 DOI: 10.1016/j.gene.2021.145966] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Martínez-Iglesias O, Carrera I, Naidoo V, Cacabelos R. AntiGan: An Epinutraceutical Bioproduct with Antitumor Properties in Cultured Cell Lines. Life (Basel) 2022;12:97. [PMID: 35054489 DOI: 10.3390/life12010097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Pan Y, Luo X, Ma J, Feng Z, Hu Y, Xue J. The dual role of interleukin-17 in the growth of human papillomavirus-negative cervical cancer cells. Eur J Inflamm 2022;20:1721727X2211280. [DOI: 10.1177/1721727x221128089] [Reference Citation Analysis]
35 Awad RM, Meeus F, Ceuppens H, Ertveldt T, Hanssens H, Lecocq Q, Mateusiak L, Zeven K, Valenta H, De Groof TW, De Vlaeminck Y, Krasniqi A, De Veirman K, Goyvaerts C, D’huyvetter M, Hernot S, Devoogdt N, Breckpot K. Emerging applications of nanobodies in cancer therapy. International Review of Cell and Molecular Biology 2022. [DOI: 10.1016/bs.ircmb.2022.03.010] [Reference Citation Analysis]
36 Miller J, Puravath AP, Orbai AM. Ixekizumab for Psoriatic Arthritis: Safety, Efficacy, and Patient Selection. J Inflamm Res 2021;14:6975-91. [PMID: 34949934 DOI: 10.2147/JIR.S229752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Yang E, Chua W, Ng W, Roberts TL. Peripheral Cytokine Levels as a Prognostic Indicator in Gastric Cancer: A Review of Existing Literature. Biomedicines 2021;9:1916. [PMID: 34944729 DOI: 10.3390/biomedicines9121916] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
38 Berry SPD, Dossou C, Kashif A, Sharifinejad N, Azizi G, Hamedifar H, Sabzvari A, Zian Z. The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases. Int Immunopharmacol 2022;102:108402. [PMID: 34863654 DOI: 10.1016/j.intimp.2021.108402] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
39 Rice SJ, Belani CP. Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer. PLoS One 2021;16:e0260988. [PMID: 34855926 DOI: 10.1371/journal.pone.0260988] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
40 Jobst J, Kobold S. Neue Strategien für die onkologische Therapie: Interleukine im Fokus. Deutsches Ärzteblatt Online 2021. [DOI: 10.3238/personko.2021.11.26.07] [Reference Citation Analysis]
41 Chung SH, Ye XQ, Iwakura Y. Interleukin-17 family members in health and disease. Int Immunol 2021;33:723-9. [PMID: 34611705 DOI: 10.1093/intimm/dxab075] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 15.0] [Reference Citation Analysis]
42 Sorrentino C, Ciummo SL, D'Antonio L, Fieni C, Lanuti P, Turdo A, Todaro M, Di Carlo E. Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome. J Immunother Cancer 2021;9:e002966. [PMID: 34663639 DOI: 10.1136/jitc-2021-002966] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Nagaoka K, Shirai M, Taniguchi K, Hosoi A, Sun C, Kobayashi Y, Maejima K, Fujita M, Nakagawa H, Nomura S, Kakimi K. Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy. J Immunother Cancer 2020;8:e001358. [PMID: 33093158 DOI: 10.1136/jitc-2020-001358] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 21.0] [Reference Citation Analysis]
44 Burger ML, Cruz AM, Crossland GE, Gaglia G, Ritch CC, Blatt SE, Bhutkar A, Canner D, Kienka T, Tavana SZ, Barandiaran AL, Garmilla A, Schenkel JM, Hillman M, de Los Rios Kobara I, Li A, Jaeger AM, Hwang WL, Westcott PMK, Manos MP, Holovatska MM, Hodi FS, Regev A, Santagata S, Jacks T. Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors. Cell 2021;184:4996-5014.e26. [PMID: 34534464 DOI: 10.1016/j.cell.2021.08.020] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 23.0] [Reference Citation Analysis]
45 Chen Y, Hou W, Zhong M, Wu B. Comprehensive Proteomic Analysis of Colon Cancer Tissue Revealed the Reason for the Worse Prognosis of Right-Sided Colon Cancer and Mucinous Colon Cancer at the Protein Level. Curr Oncol 2021;28:3554-72. [PMID: 34590603 DOI: 10.3390/curroncol28050305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Lewis JM, Monico PF, Mirza FN, Xu S, Yumeen S, Turban JL, Galan A, Girardi M. Chronic UV radiation-induced RORγt+ IL-22-producing lymphoid cells are associated with mutant KC clonal expansion. Proc Natl Acad Sci U S A 2021;118:e2016963118. [PMID: 34504008 DOI: 10.1073/pnas.2016963118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
47 Sun J, Tang Q, Zhang J, Chen G, Peng J, Chen L. Possible Immunotherapeutic Strategies Based on Carcinogen-Dependent Subgroup Classification for Oral Cancer. Front Mol Biosci 2021;8:717038. [PMID: 34497832 DOI: 10.3389/fmolb.2021.717038] [Reference Citation Analysis]
48 Sun L, Ko J, Vidimos A, Koyfman S, Gastman B. A Distinctive Lineage-Negative Cell Population Produces IL-17A in Cutaneous Squamous Cell Carcinoma. J Interferon Cytokine Res 2020;40:418-24. [PMID: 32813604 DOI: 10.1089/jir.2020.0039] [Reference Citation Analysis]
49 Mastorino L, Dapavo P, Avallone G, Merli M, Cariti C, Rubatto M, Pala V, Quaglino P, Ribero S. Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden? J Dermatolog Treat 2021;:1-8. [PMID: 34409918 DOI: 10.1080/09546634.2021.1970706] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Khan AA, Sirsat AT, Singh H, Cash P. Microbiota and cancer: current understanding and mechanistic implications. Clin Transl Oncol 2021. [PMID: 34387847 DOI: 10.1007/s12094-021-02690-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
51 Marié IJ, Brambilla L, Azzouz D, Chen Z, Baracho GV, Arnett A, Li HS, Liu W, Cimmino L, Chattopadhyay P, Silverman G, Watowich SS, Khor B, Levy DE. Tonic interferon restricts pathogenic IL-17-driven inflammatory disease via balancing the microbiome. Elife 2021;10:e68371. [PMID: 34378531 DOI: 10.7554/eLife.68371] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
52 Evans Adunyah S, Akomeah R, K.n. Arthur F, S. Cooper R, C.m. Williams J. IL-17 Biological Effects and Signaling Mechanisms in Human Leukemia U937 Cells. Interleukins - The Immune and Non-Immune Systems’ Related Cytokines 2021. [DOI: 10.5772/intechopen.96422] [Reference Citation Analysis]
53 Kartikasari AER, Huertas CS, Mitchell A, Plebanski M. Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis. Front Oncol 2021;11:692142. [PMID: 34307156 DOI: 10.3389/fonc.2021.692142] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 20.0] [Reference Citation Analysis]
54 Gowhari Shabgah A, Amir A, Gardanova ZR, Olegovna Zekiy A, Thangavelu L, Ebrahimi Nik M, Ahmadi M, Gholizadeh Navashenaq J. Interleukin-25: New perspective and state-of-the-art in cancer prognosis and treatment approaches. Cancer Med 2021;10:5191-202. [PMID: 34128588 DOI: 10.1002/cam4.4060] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
55 Kim BS, Kuen DS, Koh CH, Kim HD, Chang SH, Kim S, Jeon YK, Park YJ, Choi G, Kim J, Kang KW, Kim HY, Kang SJ, Hwang S, Shin EC, Kang CY, Dong C, Chung Y. Type 17 immunity promotes the exhaustion of CD8+ T cells in cancer. J Immunother Cancer 2021;9:e002603. [PMID: 34083422 DOI: 10.1136/jitc-2021-002603] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
56 Cui G, Li Z, Florholmen J, Goll R. Dynamic stromal cellular reaction throughout human colorectal adenoma-carcinoma sequence: A role of TH17/IL-17A. Biomed Pharmacother 2021;140:111761. [PMID: 34044278 DOI: 10.1016/j.biopha.2021.111761] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
57 Vadakekolathu J, Lai C, Reeder S, Church SE, Hood T, Lourdusamy A, Rettig MP, Aldoss I, Advani AS, Godwin J, Wieduwilt MJ, Arellano M, Muth J, Yau TO, Ravandi F, Sweet K, Altmann H, Foulds GA, Stölzel F, Middeke JM, Ciciarello M, Curti A, Valk PJM, Löwenberg B, Gojo I, Bornhäuser M, DiPersio JF, Davidson-Moncada JK, Rutella S. TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML. Blood Adv 2020;4:5011-24. [PMID: 33057635 DOI: 10.1182/bloodadvances.2020002512] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 51.0] [Reference Citation Analysis]
58 Marié IJ, Brambilla L, Azzouz D, Chen Z, Baracho G, Arnett A, Li HS, Liu W, Cimmino L, Chattopadhyay P, Silverman G, Watowich SS, Khor B, Levy DE. Tonic interferon restricts pathogenic IL-17-driven inflammatory disease via balancing the microbiome.. [DOI: 10.1101/2021.04.21.440756] [Reference Citation Analysis]
59 Bechara R, McGeachy MJ, Gaffen SL. The metabolism-modulating activity of IL-17 signaling in health and disease. J Exp Med 2021;218:e20202191. [PMID: 33822846 DOI: 10.1084/jem.20202191] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
60 Girondel C, Meloche S. Interleukin-17 Receptor D in Physiology, Inflammation and Cancer. Front Oncol 2021;11:656004. [PMID: 33833999 DOI: 10.3389/fonc.2021.656004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
61 Lee KL, Lai TC, Wang YC, Shih PC, Yang YC, Tsao TC, Liu TC, Wen YC, Chang LC, Yang SF, Chien MH. Potential Impacts of Interleukin-17A Promoter Polymorphisms on the EGFR Mutation Status and Progression of Non-Small Cell Lung Cancer in Taiwan. Genes (Basel) 2021;12:427. [PMID: 33802737 DOI: 10.3390/genes12030427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Wang X, Chen H, Jiang R, Hong X, Peng J, Chen W, Jiang J, Li J, Huang D, Dai H, Wang W, Lu J, Zhao Y, Wu W. Interleukin-17 activates and synergizes with the notch signaling pathway in the progression of pancreatic ductal adenocarcinoma. Cancer Lett 2021;508:1-12. [PMID: 33713738 DOI: 10.1016/j.canlet.2021.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
63 Bellinato F, Gisondi P, Maurelli M, Girolomoni G. IL-17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review. Dermatol Ther 2021;34:e14889. [PMID: 33595861 DOI: 10.1111/dth.14889] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
64 Džafo E, Bianchi N, Monticelli S. Cell-intrinsic mechanisms to restrain inflammatory responses in T lymphocytes. Immunol Rev 2021;300:181-93. [PMID: 33507562 DOI: 10.1111/imr.12932] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
65 Accogli T, Bruchard M, Végran F. Modulation of CD4 T Cell Response According to Tumor Cytokine Microenvironment. Cancers (Basel) 2021;13:373. [PMID: 33498483 DOI: 10.3390/cancers13030373] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
66 Cassimeris L, Engiles JB, Galantino-Homer H. Interleukin-17A pathway target genes are upregulated in Equus caballus supporting limb laminitis. PLoS One 2020;15:e0232920. [PMID: 33301461 DOI: 10.1371/journal.pone.0232920] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
67 Marcucci F, Rumio C. The tumor-promoting effects of the adaptive immune system: a cause of hyperprogressive disease in cancer? Cell Mol Life Sci 2021;78:853-65. [PMID: 32940721 DOI: 10.1007/s00018-020-03606-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
68 Cassimeris L, Engiles JB, Galantino-homer H. Interleukin-17 pathway activation in Equus caballus supporting limb laminitis.. [DOI: 10.1101/2020.04.27.063800] [Reference Citation Analysis]